Neurocognitive Disorders

65 soru

Soru 21Soru →

Match each clinical presentation to the most likely underlying neurocognitive etiology.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A patient exhibits profound early changes in personality, inappropriate social conduct, and hyperorality without initial significant memory loss.
A patient experiences an abrupt, step-wise deterioration in executive function following multiple ischemic events, accompanied by asymmetric reflex abnormalities.
A patient reports vivid recurrent formed visual hallucinations and REM sleep behavior disorder, alongside spontaneous parkinsonian features.
A patient develops a progressive triad of gait apraxia, sudden urinary urgency, and insidious cognitive slowing.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The presentations match as follows: early personality changes pair with Frontotemporal neurocognitive disorder; step-wise ischemic decline pairs with Vascular neurocognitive disorder; visual hallucinations with parkinsonism pairs with Neurocognitive disorder with Lewy bodies; and the triad of gait apraxia, urinary urgency, and cognitive slowing pairs with Normal pressure hydrocephalus.
Each neurocognitive etiology has highly specific, defining clinical features. Frontotemporal disease targets frontal lobe executive and behavioral regulation; vascular disease manifests as discrete, step-wise losses mapping to stroke territories; Lewy body pathology uniquely generates visual hallucinations and parkinsonism; and normal pressure hydrocephalus mechanically impacts periventricular tracts causing a specific triad of gait, bladder, and cognitive symptoms.

Adım Adım Çözüm

1
Analyze the first clinical presentation for distinguishing behavioral symptoms.
Identified prominent personality changes and hyperorality.
These are specific criteria for diagnosing frontotemporal neurocognitive disorder.
2
Evaluate the second presentation for onset and progression pattern.
Identified a step-wise decline associated with ischemic events.
Step-wise progression strongly indicates an underlying cerebrovascular etiology.
3
Review the third presentation for specific neuropsychiatric and sleep disturbances.
Identified visual hallucinations, REM sleep behavior disorder, and parkinsonism.
These form the classic core criteria for neurocognitive disorder with Lewy bodies.
4
Assess the fourth presentation for the classic symptomatic triad.
Identified gait apraxia, urinary incontinence, and cognitive decline.
This triad suggests impaired cerebrospinal fluid reabsorption, pointing to normal pressure hydrocephalus.

Anahtar Kavram

Distinctive clinical features of major neurocognitive disorders
Soru 22Soru →

A 72-year-old man is brought to the clinic by his wife due to a 1-year history of progressive memory decline. She reports that his cognitive abilities fluctuate significantly; on some days he is highly alert, while on other days he is deeply confused. Over the past 6 months, he has frequently reported seeing small animals in their living room, even though none are present. Additionally, his sleep is highly disturbed; he often yells and physically thrashes in bed, appearing to act out his dreams. On physical examination, the patient has a shuffling gait, a resting tremor in his right hand, and mild cogwheel rigidity. Laboratory studies reveal a thyroid-stimulating hormone (TSH) level of 2.1 µU/mL (normal: 0.4-4.0 µU/mL) and a normal vitamin B12 level. Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Dementia with Lewy bodies

Cevap

Dementia with Lewy bodies
The correct answer is Dementia with Lewy bodies. This neurodegenerative disorder is characterized by a progressive cognitive decline accompanied by distinctive core clinical features. A probable diagnosis requires the presence of dementia and at least two of the following: fluctuating cognition with pronounced variations in attention and alertness, recurrent visual hallucinations that are typically well-formed and detailed, rapid eye movement (REM) sleep behavior disorder (acting out dreams), and spontaneous features of parkinsonism (e.g., shuffling gait, resting tremor, rigidity). This patient's presentation fits perfectly with all of these classic clinical hallmarks.

Adım Adım Çözüm

1
Analyze the patient's primary symptoms and timeline.
The patient has a 1-year history of cognitive decline with marked fluctuations, recurrent visual hallucinations, REM sleep behavior disorder, and parkinsonism.
Identifying the specific combination of cognitive, psychiatric, and motor symptoms is necessary to differentiate among the neurocognitive disorders.
2
Evaluate the laboratory results.
TSH and Vitamin B12 are normal.
This rules out common reversible causes of dementia and psychosis in the elderly.
3
Match the clinical presentation to the diagnostic criteria.
The symptom profile perfectly matches the core diagnostic criteria for Dementia with Lewy bodies.
Dementia with Lewy bodies requires dementia plus two or more core features: visual hallucinations, parkinsonism, REM sleep behavior disorder, and fluctuating cognition.

Anahtar Kavram

Diagnosis of Dementia with Lewy bodies based on its core clinical features.
Soru 23Soru →

A 68-year-old retired female executive presents to an outpatient memory clinic, expressing profound distress that she is developing early-onset Alzheimer disease. She reports a 3-month history of significant cognitive decline, stating, "My brain is just broken; I can't remember anything anymore." During the Montreal Cognitive Assessment (MoCA), she makes poor eye contact and frequently answers "I don't know" to orientation and recall questions; however, when gently encouraged by the physician to guess, she answers the majority of the questions correctly. She also reports early morning awakenings, a 4.5-kg (10-lb) weight loss, and a feeling that her life lacks purpose since her retirement 4 months ago. She currently takes no medications. A recent laboratory workup shows a normal thyroid-stimulating hormone (TSH) level and a normal free T4 level. Which of the following is the most appropriate initial management step for this patient?

Cevabı ve açıklamayı göster

Cevap: Initiate a trial of a selective serotonin reuptake inhibitor and recommend psychotherapy

Cevap

Initiate a trial of a selective serotonin reuptake inhibitor and recommend psychotherapy
The correct answer addresses the underlying major depressive disorder. This patient demonstrates the classic features of 'pseudodementia'—a reversible cognitive impairment secondary to severe depression. Key distinguishing features include a relatively abrupt onset following a life stressor (retirement), acute distress and insight regarding the memory loss, and a characteristic lack of effort on cognitive testing ('I don't know' answers) that improves with encouragement. The first-line management is a combination of an SSRI and psychotherapy.

Adım Adım Çözüm

1
Analyze the patient's presentation and cognitive testing performance.
The patient complains bitterly of memory loss, exhibits vegetative symptoms of depression (weight loss, insomnia), and gives 'I don't know' answers on cognitive testing but performs well when encouraged.
Identifying the pattern of cognitive deficits helps distinguish between true neurocognitive disorders and mood disorders affecting cognition.
2
Differentiate between true major neurocognitive disorder (dementia) and pseudodementia.
Patients with true dementia typically lack insight, try to hide their deficits, and confabulate answers. Patients with pseudodementia (depression) are highly distressed by their perceived deficits and exhibit poor effort ('I don't know').
Accurate differentiation prevents the misapplication of dementia medications and guides appropriate psychiatric care.
3
Determine the most appropriate management.
Because the underlying etiology is major depressive disorder, the standard of care is to treat the depression using antidepressants (e.g., SSRIs) and psychotherapy.
Treating the underlying mood disorder in pseudodementia typically reverses the cognitive deficits.

Anahtar Kavram

Major depressive disorder in the elderly can present with prominent cognitive impairment (pseudodementia). It is distinguished from true dementia by the patient's acute awareness of deficits, distress regarding memory loss, and a tendency to give 'I don't know' answers rather than confabulating.
Tahmini Süre:1m 0s
Soru 24Soru →

Correlate the following classic clinical symptom constellations with their most appropriate neurocognitive disorder diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Fluctuating cognition, early prominent visual hallucinations, and spontaneous parkinsonism
Stepwise cognitive decline, focal neurological deficits, and evidence of cerebrovascular disease
Early personality changes, significant behavioral disinhibition, and prominent apathy
Progressive cognitive impairment, broad-based gait apraxia, and urinary incontinence

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings match each classic symptom constellation to its distinct etiology: visual hallucinations and parkinsonism indicate Dementia with Lewy bodies; stepwise decline with focal deficits points to Vascular dementia; early personality changes and disinhibition suggest Frontotemporal dementia; and the triad of gait apraxia, urinary incontinence, and dementia characterizes Normal pressure hydrocephalus.
Each neurocognitive disorder has a distinct classic presentation: Dementia with Lewy bodies presents with visual hallucinations and parkinsonism; Vascular dementia presents with stepwise decline and focal deficits; Frontotemporal dementia presents with early personality changes; and Normal pressure hydrocephalus presents with the triad of gait impairment, incontinence, and dementia.

Adım Adım Çözüm

1
Analyze the first clinical presentation featuring fluctuating cognition, hallucinations, and parkinsonism.
Identified as Dementia with Lewy bodies.
These are the hallmark core clinical criteria for diagnosing Dementia with Lewy bodies.
2
Evaluate the second presentation featuring stepwise decline and focal deficits.
Identified as Vascular dementia.
A stepwise deterioration with cerebrovascular disease evidence strongly points to a vascular etiology.
3
Review the third presentation highlighting early personality changes and disinhibition.
Identified as Frontotemporal dementia.
The behavioral variant of Frontotemporal dementia is characterized by early behavioral shifts rather than early memory loss.
4
Assess the fourth presentation with gait apraxia, incontinence, and cognitive impairment.
Identified as Normal pressure hydrocephalus.
This is the classic clinical triad ('wobbly, wacky, wet') diagnostic of Normal pressure hydrocephalus.

Anahtar Kavram

Distinctive clinical features of major neurocognitive disorders
Soru 25Soru →

A primary care physician is evaluating a 74-year-old patient who presents with her son for a routine wellness visit. The son mentions that his mother has been repeatedly asking the same questions and occasionally getting lost in familiar neighborhoods over the past year. Arrange the following steps in the most appropriate chronological order for the standard clinical evaluation and management of this patient's suspected cognitive impairment.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with obtaining a detailed history and medication review, followed by formal cognitive testing, then ruling out reversible causes with laboratory tests and neuroimaging, and finally establishing a diagnosis to guide therapy.
The standard diagnostic approach to a patient presenting with cognitive decline follows a stepwise progression to ensure accurate diagnosis while minimizing unnecessary testing. The evaluation begins with a thorough clinical history and medication review to identify obvious reversible factors, such as polypharmacy. Next, an objective cognitive screening tool (like the MoCA or MMSE) must be administered to document the presence and severity of the cognitive deficit. Once cognitive impairment is established, the clinician orders laboratory tests (including TSH and Vitamin B12) and structural neuroimaging (such as a brain MRI) to exclude reversible systemic or structural etiologies (e.g., normal pressure hydrocephalus, vascular dementia, or tumors). Finally, after reversible causes have been ruled out and a specific neurocognitive disorder (e.g., Alzheimer disease) is diagnosed, a management plan involving symptomatic pharmacotherapy can be initiated.

Adım Adım Çözüm

1
Obtain history and perform a medication review with collateral information.
Identifies the timeline of symptoms and potential iatrogenic contributors.
This is the fundamental first step in any patient evaluation to guide subsequent testing.
2
Administer an objective cognitive screen (e.g., MoCA or MMSE).
Quantifies the degree of cognitive impairment.
Objective evidence of cognitive decline is required before pursuing an expensive or invasive diagnostic workup.
3
Order laboratory tests (TSH, B12, CMP, CBC) and structural neuroimaging.
Rules out reversible causes of dementia.
Major neurocognitive disorder is largely a diagnosis of exclusion; reversible systemic or structural causes must be investigated.
4
Establish the diagnosis and initiate symptomatic treatment if appropriate.
Provides the patient and family with a management plan.
Therapies (such as cholinesterase inhibitors) can only be appropriately prescribed once the diagnosis is confirmed.

Anahtar Kavram

Diagnostic approach to neurocognitive disorders
Soru 26Soru →

A 72-year-old woman is brought to the clinic by her daughter due to a 1-year history of progressive memory loss, misplacing items, and getting lost in familiar neighborhoods. Arrange the following steps in the most appropriate chronological order for the initial diagnostic evaluation of this patient's progressive cognitive decline.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The diagnostic workup for cognitive decline sequentially involves: history and physical examination, objective cognitive screening, laboratory testing for reversible causes, and finally structural neuroimaging.
The standard approach to evaluating a patient with progressive cognitive decline follows a stepwise sequence. It begins with a comprehensive history and physical exam (including collateral history) to define the clinical syndrome. Next, an objective cognitive screening tool (e.g., MoCA, MMSE) is administered to quantify the impairment. Once impairment is confirmed, laboratory tests (TSH, Vitamin B12, CMP, CBC) are drawn to rule out reversible metabolic causes. Finally, structural neuroimaging (non-contrast CT or MRI) is obtained to rule out structural lesions (such as subdural hematoma, tumors, or normal pressure hydrocephalus) and support specific neurodegenerative diagnoses.

Adım Adım Çözüm

1
Identify the patient's presentation as suspected major neurocognitive disorder (dementia).
The patient has a 1-year history of progressive functional impairment and memory loss.
Recognizing the broad clinical syndrome guides the standard algorithmic workup.
2
Place the history and physical examination as the first action.
History and physical is ranked first.
Patient assessment universally begins with direct clinical evaluation and collateral information gathering.
3
Determine the next step to confirm the suspected diagnosis.
Objective cognitive screening is ranked second.
Subjective complaints must be verified and quantified using standardized tools like the MMSE or MoCA.
4
Sequence the diagnostic tests to rule out secondary causes.
Laboratory testing is ranked third, followed by neuroimaging as the final step in this initial workup list.
Blood work is a minimally invasive way to rapidly identify reversible metabolic causes (e.g., hypothyroidism), while structural neuroimaging completes the standard diagnostic criteria for major neurocognitive disorders by ruling out space-occupying lesions or vascular disease.

Anahtar Kavram

The standard diagnostic sequence for evaluating progressive cognitive decline.
Soru 27Soru →

A 54-year-old man is brought to the outpatient psychiatry clinic by his wife due to a 4-month history of significant behavioral changes. Previously known as a quiet and highly professional bank manager, he has recently become excessively blunt, apathetic, and socially disinhibited. Last week, he made explicit sexual remarks to a neighbor and was reprimanded at work for taking food directly off a colleague's desk. He has no prior psychiatric history. His medical history includes hypertension and hyperlipidemia. He currently takes lisinopril and atorvastatin; he also recently started occasionally taking his wife's fluoxetine. Vital signs are within normal limits. Laboratory results, including a complete blood count, comprehensive metabolic panel, and a normal thyroid-stimulating hormone (TSH) level, are unremarkable. On mental status examination, he is alert and fully oriented. His short-term memory recall is intact, but he demonstrates significant impairments on the trail-making test and verbal fluency tasks. Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Frontotemporal dementia

Cevap

Frontotemporal dementia
The most likely diagnosis is frontotemporal dementia (FTD), specifically the behavioral variant. FTD typically presents in patients between the ages of 50 and 60. The classic clinical picture involves early and profound changes in personality and behavior, including social disinhibition (e.g., inappropriate sexual remarks), apathy, loss of empathy, and hyperorality (e.g., taking food from others). Cognitive testing typically reveals prominent executive dysfunction (impaired trail-making and verbal fluency) with relatively preserved memory and visuospatial skills early in the disease course. The absence of a prior psychiatric history in a middle-aged patient with these specific behavioral changes makes a neurocognitive disorder highly likely.

Adım Adım Çözüm

1
Analyze the patient's demographic and primary symptoms.
A 54-year-old man presenting with new-onset apathy, social disinhibition, and hyperorality over 4 months.
To establish the core clinical syndrome and rule out lifelong psychiatric conditions.
2
Evaluate the cognitive testing and laboratory results.
Intact short-term memory but impaired executive function (trail-making, verbal fluency); normal TSH.
To differentiate cortical vs. subcortical, and frontal vs. temporal/parietal neurocognitive deficits, and to rule out reversible medical causes like hypothyroidism.
3
Synthesize the findings to determine the most likely etiology.
Early-onset personality changes with prominent executive dysfunction and preserved memory strongly indicate the behavioral variant of a primary neurocognitive disorder, differentiating it from pseudodementia.
To arrive at the final diagnosis of frontotemporal dementia.

Anahtar Kavram

The behavioral variant of frontotemporal dementia classically presents in patients aged 50-60 with early personality changes, social disinhibition, apathy, and executive dysfunction, while memory and visuospatial skills remain relatively intact early in the disease course.
Soru 28Soru →

A 69-year-old man is evaluated in the hospital after being admitted for urosepsis. Over the past 24 hours, he has become profoundly confused and agitated, attempting to strike the nursing staff and pull out his intravenous lines. His medical history is significant for an 11-month history of progressive cognitive decline. His wife reports that over the past year, he has had episodes of staring blankly for prolonged periods, recurrently claims to see small animals running across the living room floor, and frequently kicks and thrashes while asleep. Physical examination earlier in the admission revealed increased resistance to passive movement in all four extremities and a slow, shuffling gait. The primary team decides that pharmacological intervention is urgently necessary to prevent the patient from harming himself and staff. Administration of which of the following medications is most likely to provoke a severe, potentially fatal deterioration characterized by extreme rigidity and autonomic dysfunction in this patient?

Cevabı ve açıklamayı göster

Cevap: Haloperidol

Cevap

Haloperidol
The correct answer is haloperidol. The patient's baseline history of fluctuating cognition (staring blankly), formed visual hallucinations (seeing small animals), REM sleep behavior disorder (kicking/thrashing while asleep), and parkinsonism (rigidity, shuffling gait) is highly characteristic of Dementia with Lewy Bodies (DLB). Currently, he is experiencing delirium secondary to urosepsis. Patients with DLB have a profound, well-documented sensitivity to neuroleptic medications, particularly typical antipsychotics with strong dopamine (D2) receptor antagonism. Administration of haloperidol in these patients can precipitate a severe, potentially fatal neuroleptic sensitivity reaction. This reaction is characterized by irreversible worsening of parkinsonism, extreme rigidity, impaired consciousness, and severe autonomic dysfunction (resembling neuroleptic malignant syndrome).

Adım Adım Çözüm

1
Identify the patient's underlying primary neurocognitive disorder based on the historical and physical findings.
The patient has an 11-month history of fluctuating cognition, visual hallucinations, REM sleep behavior disorder, and parkinsonism, which firmly points to a diagnosis of Dementia with Lewy Bodies (DLB).
Accurately diagnosing the baseline neurocognitive condition is essential to guide safe pharmacological management of the superimposed acute delirium.
2
Recognize the specific pharmacological contraindications uniquely associated with this baseline diagnosis.
Patients with DLB have a profound, potentially fatal sensitivity to dopamine D2 receptor antagonists, particularly first-generation (typical) antipsychotics.
Exposure to these agents can precipitate irreversible motor deterioration, severe rigidity, and autonomic instability resembling neuroleptic malignant syndrome.
3
Evaluate the given medication options to identify the contraindicated agent.
Haloperidol is a high-potency typical antipsychotic and carries the highest risk of causing this severe neuroleptic sensitivity reaction.
Identifying the most dangerous medication ensures patient safety and avoids iatrogenic morbidity during acute behavioral disturbances.

Anahtar Kavram

Patients with Dementia with Lewy Bodies (DLB) have an extreme sensitivity to neuroleptics, particularly typical antipsychotics like haloperidol, which can precipitate life-threatening motor and autonomic deterioration.
Tahmini Süre:1m 15s
Soru 29Soru →

An 81-year-old man is brought to the primary care clinic by his son due to a 9-month history of gradual memory decline. The son reports that the patient frequently repeats questions, has stopped managing his own finances, and recently got lost while walking in his familiar neighborhood. The patient has a history of hypertension and osteoarthritis. Vital signs are within normal limits, and the physical examination is unremarkable. After completing a thorough clinical history and medication review, arrange the following steps in the diagnostic evaluation of this patient's suspected neurocognitive disorder in the most appropriate chronological order, from the immediate next step to advanced workup.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequential workup for suspected neurocognitive disorder begins with objective cognitive screening, followed by laboratory testing for reversible causes, structural neuroimaging, and finally, advanced testing (such as PET or CSF biomarkers) only if the diagnosis remains atypical or unclear.
The standard diagnostic pathway for a new presentation of cognitive decline requires confirming the deficit clinically first (using a tool like the MoCA), then ruling out reversible systemic causes (with basic labs like TSH and B12), followed by ruling out structural brain lesions (with an MRI or CT). Advanced functional or biomarker testing is only pursued if these initial steps do not yield a clear clinical picture.

Adım Adım Çözüm

1
Identify the need for objective verification of the reported cognitive decline.
Standardized cognitive assessment (e.g., MoCA) is selected as the immediate next step.
Subjective reports from family must be quantified and objectively documented before initiating a medical workup.
2
Determine the initial medical workup to rule out reversible etiologies.
Targeted laboratory tests (TSH, B12, CMP, CBC) are ordered.
Metabolic and endocrine abnormalities must be excluded as they can mimic or exacerbate major neurocognitive disorders.
3
Select the appropriate initial imaging modality.
Structural MRI of the brain is ordered.
Structural imaging is a standard part of the dementia workup to rule out macroscopic intracranial pathology like strokes, masses, or hydrocephalus.
4
Determine the role of advanced diagnostic modalities.
Functional imaging or CSF biomarkers are reserved for the end of the pathway.
These tests are expensive, invasive, or specialized, and are only indicated if the standard sequential workup is inconclusive.

Anahtar Kavram

Sequential Diagnostic Evaluation of Major Neurocognitive Disorder
Soru 30Soru →

An accompanied 71-year-old male patient presents to the geriatrics clinic for the evaluation of distressing 'visions' that have worsened over the past 11 months. According to his daughter, who lives with him, the patient frequently sees unfamiliar people sitting in their living room. These detailed visual hallucinations cause him severe agitation. Over the same timeframe, his cognitive abilities have declined, characterized by pronounced day-to-day fluctuations in attention and alertness. The daughter also reports that he often shouts and thrashes during sleep. Physical examination reveals an expressionless face, right-sided resting tremor, and cogwheel rigidity in the upper extremities. Initial non-pharmacological management, including environmental modifications, has failed to alleviate his distress. Which of the following is the most appropriate initial pharmacological therapy for this patient's visual hallucinations?

Cevabı ve açıklamayı göster

Cevap: Rivastigmine

Cevap

The correct answer is Rivastigmine.
Acetylcholinesterase inhibitors, such as rivastigmine, are the preferred first-line pharmacological therapy for cognitive and behavioral symptoms in patients with major neurocognitive disorder with Lewy bodies (DLB). When non-pharmacological interventions fail to control distressing visual hallucinations, rivastigmine is recommended because it often improves these neuropsychiatric symptoms without the severe risks associated with antipsychotic medications in this patient population.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient has a progressive neurocognitive disorder, fluctuating cognition, detailed visual hallucinations, REM sleep behavior disorder (thrashing during sleep), and spontaneous parkinsonism.
Identifying these four core clinical features establishes the underlying diagnosis of major neurocognitive disorder with Lewy bodies (DLB).
2
Identify the primary symptom requiring management.
The primary issue is severe, distressing visual hallucinations that have not responded to non-pharmacological interventions.
Management in DLB is symptom-specific, and non-pharmacological approaches are always the first step. Since they failed, pharmacotherapy is indicated.
3
Determine the first-line pharmacological therapy for this symptom in DLB.
Acetylcholinesterase inhibitors (AChEIs) such as rivastigmine or donepezil are indicated as the first-line pharmacological treatment.
Unlike primary psychotic disorders where antipsychotics are first-line, psychosis in DLB responds well to AChEIs, which avoid the high mortality and morbidity risks associated with antipsychotics in this population.

Anahtar Kavram

Acetylcholinesterase inhibitors (e.g., rivastigmine, donepezil) are the first-line pharmacological treatment for neuropsychiatric symptoms, including distressing visual hallucinations, in patients with Dementia with Lewy Bodies (DLB).
Tahmini Süre:1m 15s
Soru 31Soru →

An 82-year-old female is currently hospitalized on the medical ward for treatment of community-acquired pneumonia. On hospital day 3, the nursing staff urgently reports that the patient has become acutely agitated, is forcefully pulling at her intravenous lines, and claims she sees insects crawling on the ceiling. According to her family, she lives independently and her baseline cognitive status is fully intact. Arrange the following steps in the evaluation and management of this patient's acute change in mental status in the most appropriate chronological sequence, from the initial, most immediate action to the intervention of last resort.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for managing acute delirium is: basic vitals and stabilization, medication review, targeted laboratory diagnostics, non-pharmacological interventions, and finally, pharmacological interventions if strictly necessary.
The standard of care for acute altered mental status (delirium) requires a structured, step-wise approach. The clinician must first ensure the patient's ABCs are stable and rule out immediately life-threatening issues like hypoglycemia or hypoxia. Once stable, identifying the underlying cause begins with the least invasive and most common culprits—often medications in the hospital setting. If medication review is unrevealing or insufficient, targeted laboratory workup is the next diagnostic step to find metabolic or infectious causes. For symptom management, non-pharmacological interventions are universally the first-line treatment. Pharmacological agents (like haloperidol) are considered interventions of last resort due to their side effect profile and potential to prolong the delirious state; they are only used when the patient poses a physical danger to themselves (e.g., pulling out essential lines) and non-pharmacological measures have failed.

Adım Adım Çözüm

1
Identify the clinical syndrome
The patient is experiencing delirium, characterized by acute onset, fluctuating course, agitation, and visual hallucinations.
Recognizing the syndrome dictates the specific clinical escalation pathway, separating it from progressive major neurocognitive disorders.
2
Establish immediate safety and rule out fatal causes
Assess vitals, oxygen saturation, and capillary blood glucose.
Hypoxia, hypoglycemia, and shock can present with acute confusion and must be corrected instantly before pursuing other etiologies.
3
Investigate common, easily reversible triggers (History)
Review the inpatient medication administration record.
Hospitalized elderly patients frequently develop delirium secondary to iatrogenic causes, particularly newly administered anticholinergics, opioids, or benzodiazepines.
4
Investigate systemic physiological triggers (Diagnostics)
Order a basic metabolic panel, CBC, and potentially a urinalysis.
Electrolyte abnormalities (e.g., hypernatremia, hypercalcemia) and occult infections are major precipitants of delirium requiring targeted treatment.
5
Initiate first-line symptom management
Deploy non-pharmacological strategies (reorientation, sitter, glasses/hearing aids).
Non-pharmacological management is the evidence-based first-line therapy to safely reduce agitation without introducing new side effects.
6
Consider last-resort symptom management
Administer antipsychotics (e.g., haloperidol) only if immediate danger is present.
Chemical restraints carry a high risk of adverse events in the elderly and do not treat the underlying cause of delirium; they are reserved strictly for refractory, dangerous agitation.

Anahtar Kavram

The clinical escalation pathway for delirium prioritizes ruling out immediate life threats, followed by identifying medical/iatrogenic triggers, relying on non-pharmacological management first, and reserving antipsychotics strictly as a last resort.
Soru 32Soru →

Match each patient's core clinical presentation and disease progression pattern to the most likely neurocognitive disorder diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Insidious onset of prominent short-term memory impairment and word-finding difficulties, with later development of apraxia and agnosia.
Fluctuating cognitive impairment, recurrent well-formed visual hallucinations, and spontaneous onset of parkinsonian motor features.
Early and prominent behavioral changes, including severe disinhibition, loss of empathy, and hyperorality, with relative sparing of memory.
Stepwise decline in executive function and processing speed, typically accompanied by focal neurological deficits on physical examination.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The presentations match as follows: isolated memory loss to Alzheimer disease; fluctuating cognition with hallucinations to Lewy body dementia; early disinhibition to Frontotemporal dementia; and stepwise decline to Vascular dementia.
Each neurocognitive disorder has a distinct initial clinical signature based on the specific regions of the brain affected early in the disease process. Alzheimer disease typically begins in the medial temporal lobe, disrupting memory. Frontotemporal dementia affects the frontal and temporal lobes first, altering behavior and language. Lewy body dementia involves widespread cortical and subcortical alpha-synuclein deposition, leading to hallucinations and parkinsonism. Vascular dementia depends on stroke location but classically causes a stepwise decline corresponding to discrete ischemic events.

Adım Adım Çözüm

1
Analyze the first clinical presentation
Identified predominant early short-term memory loss and apraxia
Memory deficits followed by general cortical signs point directly to Alzheimer disease.
2
Analyze the second clinical presentation
Identified visual hallucinations, fluctuating cognition, and parkinsonism
These three symptoms form the core diagnostic criteria for Lewy body dementia.
3
Analyze the third clinical presentation
Identified behavioral disinhibition, apathy, and hyperorality without early memory loss
Severe personality and behavioral changes preceding memory deficits strongly indicate Frontotemporal dementia.
4
Analyze the fourth clinical presentation
Identified stepwise decline and focal neurological deficits
A stepwise clinical course implies sequential infarcts, pointing to Vascular dementia.

Anahtar Kavram

Differentiation of major neurocognitive disorders based on their distinct initial clinical presentations and underlying affected brain regions.
Soru 33Soru →

A 71-year-old retired architect is brought to the neurologist by his daughter due to a 9-month history of progressive cognitive decline. Initially, he began having difficulty organizing his finances and interpreting architectural blueprints. Six months ago, he started experiencing vivid episodes during sleep where he thrashes around and shouts, sometimes injuring his wife. Over the last 3 months, he has reported seeing silent, unfamiliar children playing in his living room, though he is generally not distressed by them. He has a history of major depressive disorder treated with sertraline. Two weeks ago, his primary care physician suspected an underlying bipolar diathesis but ultimately only increased his sertraline dose. A few days later, he was prescribed linezolid at an urgent care clinic for a suspected skin infection. A thyroid panel obtained last week showed a TSH of 0.1 μU/mL (normal: 0.4-4.0 μU/mL) and a free T4 of 0.6 ng/dL (normal: 0.9-1.7 ng/dL). On physical examination today, his temperature is 37.1°C (98.8°F), blood pressure is 128/82 mmHg, and heart rate is 76/min. He has a mask-like facies and increased resting muscle tone with a catch-and-release pattern in both arms. Deep tendon reflexes are 2+ bilaterally without clonus. His Mini-Mental State Examination score is 21/30. Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Major neurocognitive disorder with Lewy bodies

Cevap

Major neurocognitive disorder with Lewy bodies
The correct diagnosis is major neurocognitive disorder with Lewy bodies (DLB). DLB is characterized by progressive cognitive decline (often presenting with early executive and visuospatial deficits, as seen with this architect's difficulties) along with at least two core clinical features. This patient exhibits three core features: REM sleep behavior disorder (dream enactment behavior), recurrent well-formed visual hallucinations (silent children in the room), and spontaneous parkinsonism (mask-like facies, cogwheel rigidity). The timeline, with cognitive decline and parkinsonism occurring within 1 year of each other, differentiates it from Parkinson disease dementia.

Adım Adım Çözüm

1
Analyze the timeline and core symptoms of the patient's cognitive decline.
The patient has a 9-month history of executive dysfunction, 6 months of REM sleep behavior disorder, and 3 months of recurrent visual hallucinations.
Establishing the sequence and nature of symptoms is crucial for differentiating primary neurocognitive disorder subtypes.
2
Evaluate the physical examination findings.
The exam reveals mask-like facies and cogwheel rigidity (catch-and-release pattern), which are distinct signs of parkinsonism.
The presence of spontaneous parkinsonism, combined with the core symptoms identified in Step 1, strongly suggests Dementia with Lewy bodies.
3
Rule out iatrogenic and comorbid conditions that could mimic the presentation.
Serotonin syndrome is ruled out due to the timeline (symptoms predating linezolid) and lack of hyperreflexia/clonus. Medication-induced mania is unlikely given the absence of classic manic symptoms. Thyroid dysfunction is present (central hypothyroidism) but does not fully explain the classic triad of visual hallucinations, REM sleep disorder, and parkinsonism.
To confirm the primary neurocognitive diagnosis, acute delirium or substance-induced states must be excluded as the primary etiology.

Anahtar Kavram

Diagnosis of Dementia with Lewy bodies relies on identifying progressive cognitive decline alongside core features such as fluctuating cognition, recurrent visual hallucinations, REM sleep behavior disorder, and spontaneous parkinsonism.
Tahmini Süre:2m 0s
Soru 34Soru →

A 78-year-old man with an 8-year history of Parkinson disease is brought to the geriatrics clinic by his daughter. Over the past 6 months, he has exhibited progressive memory loss, difficulty paying bills, and fluctuating attention. During the last 2 weeks, he has developed vivid, terrifying visual hallucinations of strangers in his bedroom, leading to severe agitation. His vital signs and physical examination are unchanged from his baseline. His current medications include carbidopa-levodopa, pramipexole, trihexyphenidyl, and omeprazole. The physician determines that a stepwise approach is required to manage his neuropsychiatric symptoms while attempting to preserve motor function.

Arrange the following management steps in the most appropriate sequential order, from the initial most necessary action to the final therapy of last resort.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Evaluate for systemic causes of delirium, 2) Discontinue anticholinergics (trihexyphenidyl), 3) Taper dopamine agonists (pramipexole), 4) Initiate an acetylcholinesterase inhibitor (rivastigmine), and 5) Initiate a targeted atypical antipsychotic (quetiapine/pimavanserin).
The algorithmic management of psychosis in Parkinson disease requires a stepwise approach that balances psychiatric symptom control with motor function preservation. Any subacute change in behavior must first prompt an evaluation for delirium (e.g., infections, metabolic disturbances). Once ruled out, the physician should incrementally simplify the medication regimen. Medications with the highest risk of neuropsychiatric side effects and lowest motor benefit are discontinued first: anticholinergics (trihexyphenidyl) > amantadine > MAO-B inhibitors > dopamine agonists (pramipexole) > COMT inhibitors. Carbidopa-levodopa is reduced last, only if absolutely necessary. If psychosis persists despite optimizing the regimen, an acetylcholinesterase inhibitor (rivastigmine) is often added, particularly if cognitive impairment (Parkinson disease dementia) is present. If symptoms remain severe and distressing, an atypical antipsychotic with low D2 affinity (quetiapine, clozapine) or a 5-HT2A inverse agonist (pimavanserin) is initiated as a last resort.

Adım Adım Çözüm

1
Evaluate for systemic causes of delirium.
Identifies or excludes acute medical illnesses such as urinary tract infections or metabolic derangements.
Patients with underlying major neurocognitive disorders are highly susceptible to delirium. An acute change in mental status (over 2 weeks) mandates ruling out reversible medical causes before adjusting psychiatric or neurologic medications.
2
Simplify the antiparkinsonian regimen by discontinuing anticholinergics (trihexyphenidyl).
Removes the medication with the highest risk of causing confusion and hallucinations.
Anticholinergics impair cognition and frequently cause visual hallucinations in the elderly. They offer minimal motor benefit compared to levodopa and are the first agents to be stopped.
3
Taper and discontinue dopamine agonists (pramipexole).
Reduces dopaminergic overstimulation in the mesolimbic pathway.
If symptoms persist, other adjunctive medications (amantadine, MAO-B inhibitors, then dopamine agonists) are sequentially reduced. Dopamine agonists are notorious for causing psychosis and impulse control disorders.
4
Initiate an acetylcholinesterase inhibitor (rivastigmine).
Enhances central cholinergic transmission.
In patients with Parkinson disease dementia experiencing psychosis, cholinesterase inhibitors can improve both cognitive function and behavioral symptoms without significantly worsening motor function.
5
Initiate a low-affinity D2 receptor antagonist (quetiapine) or a 5-HT2A inverse agonist (pimavanserin).
Directly targets psychotic symptoms as a therapy of last resort.
If psychosis remains severe and distressing despite the above measures, targeted antipsychotics are used. Typical antipsychotics and most atypicals (e.g., risperidone) are contraindicated due to severe worsening of parkinsonism.

Anahtar Kavram

Algorithmic management of psychosis and agitation in Parkinson Disease Dementia.
Soru 35Soru →

A 68-year-old man is brought to the geriatric psychiatry clinic by his son for evaluation of worsening memory. The son reports that his father has been increasingly forgetful over the past 4 months, frequently missing appointments and neglecting to pay bills. The patient's wife passed away unexpectedly 6 months ago. Since her death, the patient has lost 5 kg (11 lbs), complains of waking up at 3:00 AM every morning and being unable to return to sleep, and has lost interest in his usual hobby of gardening. During the interview, the patient makes poor eye contact and appears apathetic. When asked about recent news events to test his memory, he immediately sighs and responds, "I just don't know, my memory is terrible." With significant encouragement and prompting, he is able to recall 2 out of 3 words after 5 minutes and correctly draw a clock. His physical and neurological examinations are unremarkable. Which of the following clinical features most strongly supports a diagnosis of major depressive disorder with cognitive impairment (pseudodementia) rather than Alzheimer disease in this patient?

Cevabı ve açıklamayı göster

Cevap: Tendency to highlight cognitive deficits and frequently answer "I don't know"

Cevap

The tendency to highlight cognitive deficits and frequently answer "I don't know" during testing.
Patients with major depressive disorder can develop significant cognitive impairment, a condition often termed pseudodementia. A key distinguishing feature between pseudodementia and a true neurodegenerative dementia (such as Alzheimer disease) is the patient's attitude toward their cognitive decline. Patients with pseudodementia typically have a subacute symptom onset, maintain acute insight into their deficits, frequently complain about their memory loss, and exhibit poor effort on cognitive testing (often giving up easily and defaulting to "I don't know"). In contrast, patients with Alzheimer disease typically have an insidious onset, lack insight into their deficits (anosognosia), minimize their memory loss, and will often attempt to answer questions or confabulate rather than giving up. This patient's prominent complaints about his memory and tendency to say "I don't know" before performing well with encouragement strongly point to underlying depression.

Adım Adım Çözüm

1
Identify the patient's primary symptoms and timeline.
The patient has 4 months of memory loss, apathy, weight loss, and insomnia starting 2 months after the death of his wife.
Establishes a temporal relationship between a major psychosocial stressor (bereavement) and the subacute onset of cognitive and mood symptoms.
2
Analyze the patient's behavior during the cognitive assessment.
The patient complains about his poor memory, gives poor initial effort ("I don't know"), but performs adequately with encouragement.
Differentiates the lack of effort seen in depression from the genuine loss of cognitive capacity and lack of insight seen in true dementia.
3
Compare the findings against classic presentations of major neurocognitive disorder.
Alzheimer disease typically presents with insidious onset, lack of insight (anosognosia), and attempts to guess or confabulate when unable to answer.
Confirms that the patient's presentation aligns with pseudodementia rather than a primary neurodegenerative process.

Anahtar Kavram

Differentiating major depressive disorder with cognitive impairment (pseudodementia) from primary neurodegenerative dementias like Alzheimer disease.
Tahmini Süre:1m 30s
Soru 36Soru →

A 79-year-old woman is brought to the emergency department from a memory care facility due to a 3-day history of extreme agitation and visual hallucinations. Staff report she has been picking at the air and describing "spiders on the ceiling." The patient has a 4-year history of Major Neurocognitive Disorder due to Alzheimer disease, with a baseline Mini-Mental State Examination score of 17/3017/30. Five days ago, she was evaluated for new-onset urinary incontinence, and a new medication was prescribed.

Her current daily medications include donepezil and sertraline. Her son, who is visiting from out of state and is not her legally appointed healthcare proxy (her daughter holds this role), is highly distressed and demands the physician immediately administer heavy sedatives to "calm her down."

On examination, the patient's temperature is 37.8∘C37.8^\circ\text{C} (100.0∘F100.0^\circ\text{F}), pulse is 110/min110/\text{min}, and blood pressure is 142/86 mm Hg142/86 \text{ mm Hg}. She is disoriented, continuously muttering, and unable to participate in cognitive testing. Pupils are 6 mm6 \text{ mm} bilaterally and minimally reactive to light. Mucous membranes are extremely dry. Abdominal examination reveals absent bowel sounds and a palpable, dull suprapubic mass.

Laboratory results show:
Thyroid-stimulating hormone (TSH): 0.2 \muU/mL0.2 \text{ \mu U/mL} (Normal: 0.5−5.0 \muU/mL0.5 - 5.0 \text{ \mu U/mL})
Free T4: 1.3 ng/dL1.3 \text{ ng/dL} (Normal: 0.9−1.7 ng/dL0.9 - 1.7 \text{ ng/dL})
Urinalysis: Negative for leukocyte esterase and nitrites.

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Discontinue the recently added incontinence medication and perform bladder catheterization

Cevap

Discontinue the recently added incontinence medication and perform bladder catheterization
This patient's clinical presentation is highly characteristic of acute delirium secondary to anticholinergic toxicity. She has a baseline major neurocognitive disorder (Alzheimer disease) which leaves her highly susceptible to iatrogenic delirium. Five days ago, she was started on a medication for urinary incontinence. Medications used for overactive bladder, such as oxybutynin or tolterodine, possess strong antimuscarinic (anticholinergic) properties. The classic anticholinergic toxidrome includes central nervous system effects (delirium, visual hallucinations, agitation) and peripheral autonomic effects (tachycardia, mydriasis, dry mucous membranes, decreased bowel sounds, and urinary retention, evidenced here by the palpable suprapubic mass). The most appropriate next step in management is to discontinue the offending medication and immediately decompress the bladder via catheterization, which will resolve both the pharmacologic toxicity and the severe discomfort contributing to her agitation.

Adım Adım Çözüm

1
Identify the nature of the cognitive change.
The patient has a 3-day history of extreme agitation, fluctuating consciousness, and visual hallucinations superimposed on a baseline dementia diagnosis, defining an acute delirium.
Differentiating acute delirium from progressive neurocognitive decline is the critical first step in evaluating behavioral changes in the elderly.
2
Analyze the physical examination findings.
The patient has tachycardia, mydriasis, dry mucous membranes, absent bowel sounds, and a palpable suprapubic mass indicating urinary retention.
These specific signs constitute the classic anticholinergic toxidrome ('blind as a bat, dry as a bone, red as a beet, mad as a hatter, hot as a hare').
3
Determine the precipitating cause based on the recent medical history.
The medication started 5 days ago for urinary incontinence is identified as the trigger, highly likely to be an antimuscarinic/anticholinergic drug like oxybutynin.
Anticholinergics directly oppose the action of acetylcholinesterase inhibitors (like her donepezil) and are notorious for causing delirium and urinary retention in patients with baseline cognitive impairment.
4
Formulate the most appropriate management plan.
Discontinuation of the offending anticholinergic medication and immediate placement of a urinary catheter.
Stopping the toxic agent addresses the root cause of the delirium, and decompressing the distended bladder relieves the acute pain and agitation driving the behavioral symptoms.

Anahtar Kavram

Diagnosis and management of anticholinergic delirium superimposed on major neurocognitive disorder.
Tahmini Süre:2m 30s
Soru 37Soru →

A 74-year-old retired teacher presents to the geriatrics clinic accompanied by her husband. Over the past 6 months, she has become increasingly unsteady on her feet, with her husband describing her walking as if her feet are 'glued to the floor.' Recently, she has also experienced several episodes of urinary incontinence and seems more forgetful than usual. Physical examination reveals a magnetic, broad-based gait with preserved arm swing. There are no focal motor or sensory deficits. To properly evaluate and manage this patient's most likely condition, arrange the following clinical steps in the most appropriate sequential order.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: Baseline cognitive/gait evaluation, followed by MRI of the brain, then a high-volume lumbar puncture, and finally ventriculoperitoneal shunt placement.
The appropriate management pathway for suspected Normal Pressure Hydrocephalus (NPH) begins with establishing an objective clinical baseline (gait and cognition). This is followed by neuroimaging (MRI) to document ventriculomegaly and exclude lesions that would contraindicate a lumbar puncture. Once imaging is deemed safe and consistent with NPH, a high-volume CSF tap test is performed to see if draining CSF transiently improves the patient's symptoms. A positive functional response to the tap test confirms the diagnosis and indicates that the patient will likely benefit from definitive surgical management with a ventriculoperitoneal shunt.

Adım Adım Çözüm

1
Identify the classic clinical triad presented in the vignette.
The combination of gait apraxia, urinary incontinence, and cognitive decline strongly suggests Normal Pressure Hydrocephalus (NPH).
Recognizing the syndrome is the first step in directing the targeted diagnostic workup.
2
Determine the initial non-invasive evaluation.
Standardized gait and cognitive evaluations are performed.
A formal baseline must be established so that any temporary improvement after CSF removal can be objectively measured.
3
Select the appropriate imaging modality.
MRI of the brain is obtained.
Imaging is necessary to confirm ventriculomegaly, evaluate for typical NPH findings (like DESH), and ensure there is no mass lesion that would contraindicate a lumbar puncture.
4
Confirm the diagnosis functionally.
A high-volume CSF tap test is performed.
Removing a large volume of CSF and observing transient clinical improvement strongly predicts a favorable response to surgical shunting.
5
Determine definitive management.
Ventriculoperitoneal (VP) shunt placement is scheduled.
VP shunting is the definitive treatment for patients who demonstrate a positive response to the high-volume tap test.

Anahtar Kavram

The diagnostic and therapeutic sequence for Normal Pressure Hydrocephalus requires baseline clinical assessment, neuroimaging to confirm structural criteria and safety, high-volume CSF removal to prove functional reversibility, and finally, surgical shunting.
Soru 38Soru →

A 64-year-old man is brought to the clinic by his husband for a 9-month history of progressive memory impairment, worsening apathy, and newly developed difficulty managing their household finances. His husband notes that the patient experienced a severe major depressive episode following an early retirement a year ago, which was partially responsive to a selective serotonin reuptake inhibitor. Physical and neurologic examinations reveal no focal deficits. The physician suspects a neurocognitive disorder but must carefully differentiate this from other etiologies, particularly given the prominent psychiatric history.

Arrange the following diagnostic steps in the most appropriate sequential clinical order, proceeding from the initial baseline evaluation to the most advanced, specialized investigations.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Objective cognitive screening, 2) Laboratory screening and structural neuroimaging, 3) Formal neuropsychological testing, and 4) Advanced molecular imaging or cerebrospinal fluid biomarker analysis.
The standard diagnostic algorithm for progressive cognitive decline emphasizes a stepwise escalation to minimize unnecessary testing and cost. It begins with confirming the deficit objectively (cognitive screening). Once confirmed, standard evaluation for reversible or structural etiologies is mandatory (labs and MRI). In cases where psychiatric comorbidities like depression complicate the picture, formal neuropsychological testing provides detailed cognitive profiling to distinguish between pseudodementia and true neurocognitive disorder. Finally, if the patient is relatively young (under 65) or the presentation remains atypical despite the aforementioned steps, advanced molecular imaging or CSF biomarker analysis is indicated as the definitive diagnostic tool.

Adım Adım Çözüm

1
Identify the primary clinical challenge presented by the patient's history.
The patient presents with cognitive decline and a recent history of major depressive disorder, requiring careful differentiation between true major neurocognitive disorder and pseudodementia.
Recognizing the psychiatric confounder is essential for understanding why the diagnostic workup must proceed logically to avoid premature or invasive testing.
2
Determine the required first step in any dementia evaluation algorithm.
The initial step is to objectively quantify the cognitive deficit using a standardized screening tool like the Montreal Cognitive Assessment.
Subjective complaints must be objectively verified before ordering costly laboratory tests or imaging studies.
3
Identify the standard medical workup that follows confirmation of a cognitive deficit.
Basic laboratory tests (e.g., TSH, vitamin B12) and structural neuroimaging (e.g., MRI) are ordered next.
This is universally recommended by guidelines to rule out reversible metabolic, endocrine, or structural causes of cognitive decline.
4
Place specialized diagnostic tests in the correct escalation sequence for ambiguous cases.
Formal neuropsychological testing follows the standard workup to clarify the etiology (depression vs. neurodegeneration). If the diagnosis remains uncertain (especially in early-onset cases), advanced biomarker testing (PET/CSF) is the final step.
Diagnostic escalation moves systematically from non-invasive, low-cost screening to comprehensive cognitive profiling, and finally to highly specialized biomarker analysis.

Anahtar Kavram

The diagnostic algorithm for neurocognitive disorders proceeds sequentially from objective cognitive screening, to ruling out reversible/structural causes (labs/MRI), to differentiating complex psychiatric mimics via neuropsychological testing, and finally to advanced biomarker analysis for atypical cases.
Soru 39Soru →

An 82-year-old man arrives at the emergency department accompanied by his daughter due to severe agitation, disorientation, and visual hallucinations that began acutely 4848 hours ago. He repeatedly points to the corner of the room, claiming that intruders are hiding there. His daughter notes that over the past 33 years, he has developed mild forgetfulness, such as occasionally misplacing his keys, but he has always remained independent in his daily activities. His medical history includes hypertension, osteoarthritis, and major depressive disorder. His daily medications include lisinopril and fluoxetine. Two weeks ago, he was prescribed tramadol for worsening knee pain. Vital signs show a temperature of 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure of 130/80 mmHg130/80\text{ mmHg}, and a heart rate of 82/min82\text{/min}. Physical examination reveals no focal neurologic deficits, normal muscle tone, and absent clonus. He is unable to recite the months of the year backward. Laboratory testing reveals a thyroid-stimulating hormone (TSH) level of 2.1 μU/mL2.1\text{ }\mu\text{U/mL} (normal: 0.5−5.0 μU/mL0.5-5.0\text{ }\mu\text{U/mL}) and free thyroxine (T4) of 1.2 ng/dL1.2\text{ ng/dL} (normal: 0.9−2.4 ng/dL0.9-2.4\text{ ng/dL}). Urinalysis is positive for leukocyte esterase, nitrites, and numerous leukocytes. What is the most accurate diagnosis for this patient's current presentation?

Cevabı ve açıklamayı göster

Cevap: Delirium due to another medical condition

Cevap

The most accurate diagnosis is delirium due to another medical condition.
The patient presents with an acute onset of fluctuating attention, disorientation, and visual hallucinations. In an elderly patient with a history of mild underlying cognitive decline, these findings are hallmark features of delirium. The positive urinalysis indicates a urinary tract infection, which is a highly common precipitant of delirium in this age group. The inability to recite the months of the year backward demonstrates the core deficit of inattention.

Adım Adım Çözüm

1
Identify the core clinical syndrome based on the time course and mental status examination.
The patient has an acute onset (4848 hours) of fluctuating attention (inability to recite months backward), disorientation, and visual hallucinations.
Establishing the primary syndrome narrows the differential diagnosis to acute neurocognitive disorders (delirium) versus primary psychiatric illnesses.
2
Evaluate the medical context and diagnostic test results to identify an underlying etiology.
The patient has a positive urinalysis indicative of a urinary tract infection (UTI) and normal vital signs without neuromuscular hyperreactivity.
Identifying an underlying systemic illness (UTI) explains the acute cognitive changes, confirming a diagnosis of delirium and ruling out medication-induced toxidromes like serotonin syndrome.

Anahtar Kavram

Delirium is an acute, fluctuating neurocognitive disorder characterized by inattention and disorganized thinking or altered level of arousal, most commonly triggered by an underlying medical condition such as an infection in elderly patients.
Tahmini Süre:1m 30s
Soru 40Soru →

An 8080-year-old man with a history of moderate Alzheimer disease and benign prostatic hyperplasia is brought to the emergency department by his daughter, who is his legally appointed healthcare proxy. Over the past 4848 hours, he has become acutely agitated, disoriented, and has been grasping at invisible objects. Two days ago, he started taking an over-the-counter diphenhydramine preparation for insomnia. The patient's visiting son arrived today and insists the patient be transferred immediately to a psychiatric facility. A recent outpatient urine culture grew >105 CFU/mL>10^5 \text{ CFU/mL} of Escherichia coli sensitive to nitrofurantoin and cephalexin. Recent thyroid tests showed a serum thyroid-stimulating hormone of 1.5 μU/mL1.5 \ \mu\text{U/mL} (normal: 0.4−4.0 μU/mL0.4-4.0 \ \mu\text{U/mL}) and a free thyroxine of 0.5 ng/dL0.5 \text{ ng/dL} (normal: 0.9−2.4 ng/dL0.9-2.4 \text{ ng/dL}). Vital signs show a temperature of 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure 135/85 mm Hg135/85 \text{ mm Hg}, pulse 108/min108\text{/min}, and respirations 16/min16\text{/min}. Physical examination reveals dry oral mucosa, flushed skin, and a palpably distended bladder. Which of the following is the most appropriate initial management for this patient?

Cevabı ve açıklamayı göster

Cevap: Insertion of a urethral catheter and discontinuation of the sleep aid

Cevap

The most appropriate initial management is the insertion of a urethral catheter and discontinuation of the sleep aid.
The patient is experiencing acute delirium secondary to anticholinergic toxicity, directly precipitated by the recent use of over-the-counter diphenhydramine. Patients with pre-existing neurocognitive disorders, such as Alzheimer disease, have diminished cognitive reserves and are exquisitely sensitive to the central effects of anticholinergic medications. The patient's clinical picture is a textbook presentation of the anticholinergic toxidrome, which includes altered mental status and hallucinations ('mad as a hatter'), dry mucous membranes ('dry as a bone'), cutaneous vasodilation ('red as a beet'), tachycardia, and urinary retention ('full as a flask'). The urinary retention is further exacerbated by his underlying benign prostatic hyperplasia. The most appropriate initial management is to physically address the acute urinary retention via bladder catheterization and to immediately discontinue the offending pharmacological agent.

Adım Adım Çözüm

1
Analyze the acute clinical presentation.
The patient exhibits acute agitation, visual hallucinations, tachycardia, dry mucosa, flushed skin, and a distended bladder developing over 48 hours.
Identifying the symptom cluster is required to recognize a specific toxicological or medical syndrome.
2
Correlate symptoms with the recent history.
The symptoms align perfectly with anticholinergic toxicity ('mad as a hatter, dry as a bone, red as a beet, full as a flask') triggered by the initiation of over-the-counter diphenhydramine.
Elderly patients with underlying neurocognitive disorders like Alzheimer disease are highly susceptible to the side effects of anticholinergic medications.
3
Determine the most immediate medical intervention required.
The palpable bladder indicates acute urinary retention, exacerbated by benign prostatic hyperplasia and the anticholinergic load. This must be relieved immediately.
Acute urinary retention causes severe agitation in cognitively impaired patients and can lead to renal injury if left untreated.
4
Evaluate and rule out the distracting information.
The psychiatric symptoms are secondary to delirium, not primary psychosis. The UTI is known to be sensitive to narrow-spectrum agents. The thyroid labs indicate central (secondary) hypothyroidism. The son has no legal authority over the appointed proxy.
Ensures the chosen management directly addresses the acute, life-threatening issue without committing clinical or ethical errors.

Anahtar Kavram

Diagnosis and management of delirium superimposed on a major neurocognitive disorder due to anticholinergic toxicity and acute urinary retention.
ÖncekiSayfa 2 / 4Sonraki
Neurocognitive Disorders Alıştırma Soruları — USMLE Step 2 CK — Sayfa 2 | Examkin